SCHEMBL7679937

SCHEMBL7679937

c1ccc(CCC2=NN=C(c3cccnc3)[N]2)cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 3/20 0.48
RAB9A P51151 3/20 0.48
CYP11B1 P15538 3/20 0.45
CYP11B2 P19099 3/20 0.45
ALDH1A1 P00352 3/20 0.43
L3MBTL1 Q9Y468 2/20 0.43
MAPT P10636 2/20 0.43
TSHR P16473 1/20 0.43
HTT P42858 1/20 0.43
ATM Q13315 1/20 0.43
GPR84 Q9NQS5 1/20 0.43
CYP1A2 P05177 3/20 0.41
CYP3A4 P08684 3/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
CYP2A6 P11509 1/20 0.41
CYP2C19 P33261 2/20 0.41
USP2 O75604 1/20 0.41
CYP2D6 P10635 1/20 0.41
CLK4 Q9HAZ1 1/20 0.41
FAAH O00519 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7683441 0.86 CYP11B1 (0.49) NPC1RAB9ACYP11B1CYP11B2ALDH1A1
SCHEMBL7673098 0.81 KMT2A (0.43) NPC1RAB9ACYP11B1CYP11B2ALDH1A1
SCHEMBL7680165 0.78 TBXAS1 (0.51)
SCHEMBL7676360 0.78 CYP2A6 (0.40) CYP11B1CYP11B2ALDH1A1L3MBTL1MAPT
SCHEMBL7676187 0.78 CYP2A6 (0.47) CYP11B1CYP11B2ALDH1A1MAPTHTT
SCHEMBL7674967 0.78 MKNK1 (0.50) ALDH1A1MAPTHTTCYP1A2CYP3A4
SCHEMBL7680376 0.77 KDM4E (0.47) RAB9ACYP11B1CYP11B2ALDH1A1L3MBTL1
SCHEMBL7673942 0.75 CYP2A6 (0.44) NPC1RAB9ACYP11B1CYP11B2ALDH1A1
SCHEMBL7674216 0.74 CYP2A6 (0.50) NPC1RAB9AALDH1A1MAPTTSHR
SCHEMBL8700016 0.72 CYP1A2 (0.66) L3MBTL1GPR84CYP1A2CYP2A6CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6376490-B1 STRONG N-METHYL-D-ASPARATE RECEPTOR ANTAGONISTS; USEFUL IN TREATING STROKES, ISCHEMIA, AND CENTRAL NERVOUS SYSTEM INJURIES PFIZER INC 2002-04-23 US claimed
EP-0885212-B1 QUINOXALINEDIONES PFIZER RES AND BR DEV COMPANY (IE) 2001-11-14 EP claimed
JP-3110467-B2 2000-11-20 JP claimed
EP-0885212-A1 QUINOXALINEDIONES Pfizer Research and Development Company, N.V./S.A. (IE) 1998-12-23 EP claimed
WO-1997032873-A1 QUINOXALINEDIONES PFIZER RESEARCH AND DEVELOPMENT COMPANY, N.V./S.A. (IE) 1997-09-12 WO claimed
EP-0885212-B1 QUINOXALINEDIONES PFIZER RES AND BR DEV COMPANY (IE) 2001-11-14 EP disclosed
EP-0885212-A1 QUINOXALINEDIONES Pfizer Research and Development Company, N.V./S.A. (IE) 1998-12-23 EP disclosed
WO-1997032873-A1 QUINOXALINEDIONES PFIZER RESEARCH AND DEVELOPMENT COMPANY, N.V./S.A. (IE) 1997-09-12 WO disclosed